Health
Anticoagulation therapy associated with improved survival among COVID-19 patients – News-Medical.Net
Early in the COVID-19 pandemic, Mount Sinai researchers were among the first to show that anticoagulation therapy was associated with improved survival among hospitalized COVID-19 patients
Early in the COVID-19 pandemic, Mount Sinai researchers were among the first to show that anticoagulation therapy was associated with improved survival among hospitalized COVID-19 patients. But many questions remained-;about the size of the potential benefit, and about what dosage of this therapy might be more effective.
Now, the research team has suggested some possible answers, in a paper published in the August 26 online issue of the Journal of the American College of Cardiology.
In this ob…
-
Business15 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
General22 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business17 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business14 hours agoHere’s what analysts expect for the BHP share price in the coming year